National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 49041 [2021-18860]
Download as PDF
49041
Federal Register / Vol. 86, No. 167 / Wednesday, September 1, 2021 / Notices
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Cesar E. Perez-Gonzalez,
Training Director, Office of the
Scientific Director, National Eye
Institute, NIH, Building 31, Room 6A22,
MSC 0250, Bethesda, Maryland 20892
or call non-toll-free number (301) 451–
6763 or Email your request, including
your address to: cesarp@nei.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of August 26, 2021,
in FR Doc. 2021–18393, on page 47652, as
found within the SUPPLEMENTARY
INFORMATION section, within the Estimated
Annualized Burden Hours table for the
Number of Responses per Respondent
column total currently reads ‘‘150’’ and is
corrected to read: ‘‘450’’.
Daniel R. Hernandez,
NIH Federal Register Certifying Official,
National Institutes of Health.
Dated: August 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18860 Filed 8–31–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–18812 Filed 8–31–21; 8:45 am]
BILLING CODE 4140–01–P
Substance Abuse and Mental Health
Services Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases,
Special Emphasis Panel; Time Sensitive
Obesity.
Date: September 28, 2021.
Time: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Video
Meeting).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353,
6707 Democracy Boulevard, Bethesda, MD
20892–2542, (301) 594–8898, barnardm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
0361.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
Number of
respondents
(states/
jurisdictions)
Type of activity
TEDS Admission Data .........................................................
VerDate Sep<11>2014
18:03 Aug 31, 2021
Jkt 253001
PO 00000
Frm 00070
Responses
per
respondent
52
Fmt 4703
Sfmt 4703
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Treatment Episode
Data Set (TEDS) (OMB No. 0930–
0335)—Extension
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting an extension to
collect the Treatment Episode Data Set
(TEDS) data collection (OMB No. 0930–
0335), which expires on April 30, 2022.
TEDS is a compilation of client-level
substance use treatment admission and
discharge data submitted by states on
clients treated in facilities that receive
state funds. SAMHSA is also requesting
an extension to collect the client-level
mental health admission and update/
discharge data (MH–TEDS/MH–CLD)
submitted by states on clients treated in
facilities that receive state funds (also
OMB No. 0930–0335).
TEDS/MH–TEDS/MH–CLD data are
collected to obtain information on the
number of admissions and updates/
discharges at publicly funded substance
use treatment and mental health
services facilities and on the
characteristics of clients receiving
services at those facilities.
TEDS/MH–TEDS/MH–CLD also
monitor trends in the demographic,
substance use, and mental health
characteristics of admissions. In
addition, several of the data elements
used to calculate performance measures
for the Substance Abuse Block Grant
(SABG) and Mental Health Block Grant
(MHBG) applications are collected
through the TEDS/MH–TEDS/MH–CLD.
Most states collect the TEDS/MH–
TEDS/MH–CLD data elements from
their treatment providers for their own
administrative purposes and are able to
submit a cross-walked extract of their
data to TEDS/MH–TEDS/MH–CLD. No
changes are expected in the TEDS/MH–
TEDS/MH–CLD data elements that are
collected.
Estimated annual burden for the
separate TEDS/MH–TEDS/MH–CLD
activities is as follows:
Total
responses
4
E:\FR\FM\01SEN1.SGM
208
01SEN1
Hours per
response
6.25
Total burden
hours
1,300
Agencies
[Federal Register Volume 86, Number 167 (Wednesday, September 1, 2021)]
[Notices]
[Page 49041]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18860]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases, Special Emphasis Panel; Time Sensitive Obesity.
Date: September 28, 2021.
Time: 3:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Video Meeting).
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Officer, Review Branch, Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892-2542, (301) 594-8898,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: August 27, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18860 Filed 8-31-21; 8:45 am]
BILLING CODE 4140-01-P